Replimune Group, Inc. (REPL): Price and Financial Metrics
REPL Price/Volume Stats
| Current price | $12.49 | 52-week high | $17.00 |
| Prev. close | $12.01 | 52-week low | $4.92 |
| Day low | $11.43 | Volume | 2,350,600 |
| Day high | $13.04 | Avg. volume | 1,052,708 |
| 50-day MA | $12.20 | Dividend yield | N/A |
| 200-day MA | $9.59 | Market Cap | 854.53M |
REPL Stock Price Chart Interactive Chart >
Replimune Group, Inc. (REPL) Company Bio
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer. It is developing various proprietary products intended to enhance the direct anti-tumor effects of selective virus replication and the potency of the immune response to the tumor antigens released. The company was founded in 2015 is based in Abingdon, the United Kingdom.
REPL Price Returns
| 1-mo | 13.03% |
| 3-mo | 14.48% |
| 6-mo | 42.58% |
| 1-year | 53.25% |
| 3-year | -55.33% |
| 5-year | -18.15% |
| YTD | 48.16% |
| 2023 | -69.01% |
| 2022 | 0.37% |
| 2021 | -28.96% |
| 2020 | 165.85% |
| 2019 | 43.50% |
Loading social stream, please wait...